Back to top
more

Medidata Solutions, Inc. (MDSO)

(Delayed Data from NSDQ)

$93.97 USD

93.97
732,048

+1.49 (1.61%)

Updated May 3, 2019 04:00 PM ET

After-Market: $93.97 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

Medidata Solutions (MDSO) Earnings Expected to Grow: What to Know Ahead of Q3 Release

Medidata (MDSO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Medidata (MDSO) Collaborates With Mapi Research to Boost Rave

Medidata's (MDSO) latest collaboration is expected to solve major eCOA implementation struggles in the pharmaceutical industry.

Medidata (MDSO) Up 0.8% Since Last Earnings Report: Can It Continue?

Medidata (MDSO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Medidata (MDSO) Earnings and Revenues Beat Estimates in Q2

Medidata (MDSO) gains from solid segmental contributions in Q2.

Earnings Preview: Medidata Solutions (MDSO) Q2 Earnings Expected to Decline

Medidata (MDSO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Stock Market News For Jun 14, 2019

Markets closed in the green on Thursday after energy shares rallied following an attack on oil tankers in the Gulf of Oman.

Medidata (MDSO) to be Acquired by Dassault for $5.8 Billion

Dassault's acquisition of Medidata (MDSO) to close by 2019-end.

Here's Why You Should Hold on to Medidata (MDSO) Stock Now

Medidata Solutions (MDSO) continues to benefit from solid R&D focus, Rave Genomics platform and cloud-based services. However, stiff competition remains a concern.

Medidata (MDSO) Down 1.9% Since Last Earnings Report: Can It Rebound?

Medidata (MDSO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Medidata (MDSO) Q1 Earnings Beat Estimates, Margins fall

Medidata (MDSO) witnesses year-over-year revenue growth in double-digits across both operating segments in first-quarter 2019.

Will Flagship Impella Drive ABIOMED's (ABMD) Q4 Earnings?

ABIOMED's (ABMD) fourth-quarter results are likely to gain from flagship Impella despite foreign exchange headwinds.

Why the Earnings Surprise Streak Could Continue for Medidata (MDSO)

Medidata (MDSO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

DexCom (DXCM) to Report Q1 Earnings: What's in the Offing?

DexCom's (DXCM) G6 censors and lucrative collaborations are likely to drive Q1 results.

Medidata Solutions (MDSO) Expected to Beat Earnings Estimates: Should You Buy?

Medidata (MDSO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BioTelemetry (BEAT) to Report Q1 Earnings: What's in Store?

Products like MCT and Ware Holter are likely to aid BioTelemetry (BEAT) in Q1.

Cerner (CERN) to Report Q1 Earnings: What's in the Offing?

Top-line growth and solid show by Population Health, Revenue Cycle and IT Works are likely to aid Cerner (CERN) in Q1. However, expected decline in bookings is likely to be a dampener.

Can Diagnostic Revenues Fuel PerkinElmer's (PKI) Q1 Earnings?

Strength in PerkinElmer's (PKI) core Diagnostics business is expected to drive Q1 results amid foreign exchange woes.

Sweta Jaiswal headshot

Bright Near-Term Outlook for Medical Info Systems Industry

The wave of digital transition is helping players in the Zacks Medical Info Systems industry to open up bountiful opportunities for investors.

Medidata Launches Acorn Artificial Intelligence Company

Driven by Medidata's (MDSO) standardized clinical data storehouse, and operating on its pioneering platform, Acorn AI is set to become one of the premier AI companies in the field of life sciences.

Medidata (MDSO) Surges: Stock Moves 7.5% Higher

Medidata (MDSO) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.

Earnings Preview: Medidata Solutions (MDSO) Q1 Earnings Expected to Decline

Medidata (MDSO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Why Is Medidata (MDSO) Up 3.4% Since Last Earnings Report?

Medidata (MDSO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Medidata's (MDSO) Margins Under Pressure, Competition Rife

Medidata (MDSO) suffers from cutthroat competition in the clinical trial solutions market at the moment.

Medidata (MDSO) Q4 Earnings Beat, Revenues Miss Estimates

Medidata (MDSO) gains from solid segmental performance in Q4.

Medidata Solutions (MDSO) Surpasses Q4 Earnings Estimates

Medidata (MDSO) delivered earnings and revenue surprises of 21.62% and -0.34%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?